Selonterra is a biopharmaceutical company that works on Alzheimer's and Parkinson's disease therapies and diagnostics.
Selonterra has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Selonterra's investors include Michael J. Fox Foundation.
Selonterra is headquartered in San Mateo, United States.
Selonterra is a biopharmaceutical company that works on Alzheimer's and Parkinson's disease therapies and diagnostics.
Selonterra is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Selonterra — Funding & Investors." VCBacked, October 8, 2024, https://www.vcbacked.co/company/selonterra. Accessed August 13, 2026.
VCBacked. (2024). Selonterra — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/selonterra
{{cite web |title=Selonterra — Funding & Investors |url=https://www.vcbacked.co/company/selonterra |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated